AKT1 and type 2 diabetes mellitus: The present study was firstly conducted in the model of T2DM mice with HUA, and demonstrated that empagliflozin treatment improved HUA through enhancing ABCG2 expression via AMPK/AKT/CREB pathway in both kidney and ileum.